A Team Dedicated to Transforming Lives Through Science and Compassion
At Vermillion Health, our team brings together passionate clinicians, engineers, and innovators with a shared mission: to create safe, effective, clinically validated solutions that reduce suffering and help people live fuller lives.
Our Belief
Our Journey
Our Expertise
Our Vision
The Exsurgo Team
EXECUTIVE TEAM
Duncan clement
Chief Operating Officer
Chief Technology Officer
ROBERT IRVING
Production Manager
John Emson
Chief Financial Officer
Robert is an award-winning medical device engineer; he was Richard’s cofounder on the Rex project and has a solid background of transforming medical device engineering concepts into volume manufactured products. Robert’s production engineering background includes medical device quality and regulatory certification and compliance of production facilities.
John has spent over 30 years in finance and M&A across the technology, manufacturing, health and education sectors. In his CFO role, John’s focus will be on ensuring Exsurgo has the operational and financial systems to handle its anticipated rapid growth, including compliance with regulatory obligations in a range of key overseas target markets. John has an MBA from the University of Birmingham and moved to New Zealand from the UK in 2015.
Jiva has extensive experience encompassing the complete product lifecycle from product development through to manufacturing and market approvals. He has 18 years experience in the medical devices industry with Fisher & Paykel Healthcare, Rex Bionics and Dynamic Controls (an Invacare subsidiary). He has held roles in engineering, R&D management, marketing, global product management, quality and regulatory management. He has a Bachelor of Engineering and a Master of Engineering Studies in Medical Devices and Technologies from Auckland University.
BOARD OF DIRECTORS
DAvID ROSS
Chairman
Chief Technology Officer
Mike Wombwell
Independent Director
yALMAN A kHAN
Independent Director
CLINICAL and science ADVISORS
JON GRAHAM
Clinical Advisor
CHRISTINE OZOLINS
Science Advisor
Christine believes we are only just beginning to understand the amazing power and adaptability of the human brain. A Psychologist and Cognitive Neuroscientist specialising in neuroimaging and brain modulation techniques, Christine has conducted academic research into the effects of neurofeedback on creativity, attention, memory and perception. She has also worked on research projects and clinical trials involving learning, memory, attention and dementia, involving paediatric, geriatric and clinical populations.
Christine first encountered neurofeedback in 2015 in London where she was inspired by how neurofeedback could combine behavioural psychology with neuroscientific principles to help people self-regulate their brain activity.
Since joining Exsurgo in 2019, Christine designed and ran the UK proof of concept study during the Covid-19 pandemic, supporting participants throughout the trial. Christine is overseeing several upcoming trials, including the world’s largest clinical trial of Electroencephalography (EEG) neurofeedback for chronic pain, and studies using the Axon system to treat anxiety, trauma and the detection, prediction and treatment of concussion.
The Exsurgo Team
EXSURGO TEAM
Chief Executive
Chief Operating Officer
Chief Technology Officer
ROBERT IRvING
Production Engineering
JOHN EMSON
Chief Financial Officer
John has spent over 30 years in finance and M&A across the technology, manufacturing, health and education sectors. In his CFO role, John’s focus will be on ensuring Exsurgo has the operational and financial systems to handle its anticipated rapid growth, including compliance with regulatory obligations in a range of key overseas target markets. John has an MBA from the University of Birmingham and moved to New Zealand from the UK in 2015.
Joining the Exsurgo team in 2020, I drive transformative initiatives, overseeing clinical trials and navigating capital endeavours in the UAE, and advancing product innovation in the UK and UAE markets. With a passion to lead the future of HealthTech, I am committed to translating scientific advancements into impactful solutions in the Chronic Pain space. I envision reshaping the landscape of neurological well-being. Together, we’re dedicated to curing the world, one session at a time.
BOARD OF DIRECTORS
DAvID ROSS
Chairman
Chief Technology Officer
MIKE WOMBWELL
Independent Director
Clinical and Science Advisors
JON GRAHAM
Clinical Advisor
Christine Ozolins
Science Advisor
Christine believes we are only just beginning to understand the amazing power and adaptability of the human brain. A Psychologist and Cognitive Neuroscientist specialising in neuroimaging and brain modulation techniques, Christine has conducted academic research into the effects of neurofeedback on creativity, attention, memory and perception. She has also worked on research projects and clinical trials involving learning, memory, attention and dementia, involving paediatric, geriatric and clinical populations.
Christine first encountered neurofeedback in 2015 in London where she was inspired by how neurofeedback could combine behavioural psychology with neuroscientific principles to help people self-regulate their brain activity.
Since joining Exsurgo in 2019, Christine designed and ran the UK proof of concept study during the Covid-19 pandemic, supporting participants throughout the trial. Christine is overseeing several upcoming trials, including the world’s largest clinical trial of Electroencephalography (EEG) neurofeedback for chronic pain, and studies using the Axon system to treat anxiety, trauma and the detection, prediction and treatment of concussion.
Keep up to date with the latest Exsurgo progress